Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.
Despite an increasing awareness of the importance of innate immunity, the roles of natural killer (NK) cells in transplant rejection and antiviral and cancer immunity during immunosuppression have not been clearly defined.To address this issue we have developed a quantitative assay of NK cell functi...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-10-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2953494?pdf=render |
id |
doaj-df251f31bad24b8f81eabafa329a224d |
---|---|
record_format |
Article |
spelling |
doaj-df251f31bad24b8f81eabafa329a224d2020-11-24T20:45:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-10-01510e1329410.1371/journal.pone.0013294Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.Olivier MorteauSamkeliso BlundellAron ChakeraSophia BennettCharita M ChristouPhilip D MasonRichard J CornallChristopher A O'CallaghanDespite an increasing awareness of the importance of innate immunity, the roles of natural killer (NK) cells in transplant rejection and antiviral and cancer immunity during immunosuppression have not been clearly defined.To address this issue we have developed a quantitative assay of NK cell function that can be used on clinical samples and have studied the influence of immunosuppression on NK cell function. NK cell degranulation and intracellular interferon (IFN)-γ production were determined by flow cytometry of peripheral blood samples.Overnight ex vivo treatment of peripheral blood cells from healthy controls with ciclosporin or tacrolimus inhibited NK cell degranulation and IFN-γ production in a dose-dependent manner. A similar impairment of function was seen in NK cells from patients treated in vivo with calcineurin inhibitors. In the early post-transplant period, there was a variable reduction of NK cell counts after treatment with alemtuzumab and basiliximab.The functional inhibition of NK cells in early transplant patients coincides with the period of maximum susceptibility to viral infections. The ability to assay NK cell function in clinical samples allows assessment of the impact of immunosuppression on these effector cells. This information may be helpful in guiding the titration of immunosuppression in the clinical setting.http://europepmc.org/articles/PMC2953494?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Olivier Morteau Samkeliso Blundell Aron Chakera Sophia Bennett Charita M Christou Philip D Mason Richard J Cornall Christopher A O'Callaghan |
spellingShingle |
Olivier Morteau Samkeliso Blundell Aron Chakera Sophia Bennett Charita M Christou Philip D Mason Richard J Cornall Christopher A O'Callaghan Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. PLoS ONE |
author_facet |
Olivier Morteau Samkeliso Blundell Aron Chakera Sophia Bennett Charita M Christou Philip D Mason Richard J Cornall Christopher A O'Callaghan |
author_sort |
Olivier Morteau |
title |
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
title_short |
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
title_full |
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
title_fullStr |
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
title_full_unstemmed |
Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
title_sort |
renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-10-01 |
description |
Despite an increasing awareness of the importance of innate immunity, the roles of natural killer (NK) cells in transplant rejection and antiviral and cancer immunity during immunosuppression have not been clearly defined.To address this issue we have developed a quantitative assay of NK cell function that can be used on clinical samples and have studied the influence of immunosuppression on NK cell function. NK cell degranulation and intracellular interferon (IFN)-γ production were determined by flow cytometry of peripheral blood samples.Overnight ex vivo treatment of peripheral blood cells from healthy controls with ciclosporin or tacrolimus inhibited NK cell degranulation and IFN-γ production in a dose-dependent manner. A similar impairment of function was seen in NK cells from patients treated in vivo with calcineurin inhibitors. In the early post-transplant period, there was a variable reduction of NK cell counts after treatment with alemtuzumab and basiliximab.The functional inhibition of NK cells in early transplant patients coincides with the period of maximum susceptibility to viral infections. The ability to assay NK cell function in clinical samples allows assessment of the impact of immunosuppression on these effector cells. This information may be helpful in guiding the titration of immunosuppression in the clinical setting. |
url |
http://europepmc.org/articles/PMC2953494?pdf=render |
work_keys_str_mv |
AT oliviermorteau renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT samkelisoblundell renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT aronchakera renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT sophiabennett renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT charitamchristou renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT philipdmason renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT richardjcornall renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo AT christopheraocallaghan renaltransplantimmunosuppressionimpairsnaturalkillercellfunctioninvitroandinvivo |
_version_ |
1716814772711718912 |